How did adult women's fear of COVID-19 affect their attitudes toward cervical cancer screening? An example of Turkey
Abstract
This descriptive cross-sectional study was carried out between May and December 2021 in Turkey to examine the effect of adult women's fear of COVID-19 on their attitudes toward Cervical Cancer (CC) screening. The study population consisted of 334 women between the ages of 30 and 65 years according to the criteria of the national standards for the CC screening program in Turkey. A socio-demographic data form (21 questions) and the fear of COVID-19 Scale (7 questions) were used for data collection. The mean score of women for the level of knowledge about cervical cancer screening was 6.16 ± 3.05 out of a total score of 10. The mean score of the Fear of COVID-19 scale was 19.20 ± 6.12 out of a total score of 35. Cause of the risk of COVID-19 contamination 25.4 % of women postponed their CC screening. Women’s knowledge about cervical cancer screening was found to be moderate, and their fear of coronavirus was found to be close to moderate. It was determined that women with a high fear of coronavirus postponed their CC screening tests.
Full Text:
PDFReferences
International Agency for Research of Cancer (IARC) 2020b. Globocan 2020, Cervix uteri. 2020.https://gco.iarc.fr/today.
International Agency for Research of Cancer (IARC) 2020a. Population Fact Sheets. 2020.https://gco.iarc.fr/today/fact-sheets-populations (accessed 2 Nov2022).
T.R. Ministry of Health, General Directorate of Public Health. Türkiye Kanser İstatistikleri. 2016.https://hsgm.saglik.gov.tr/depo/birimler/kanser-db/istatistik/Turkiye_Kanser_Istatistikleri_2016.pdf (accessed 2 Nov2022).
Berman TA, Schiller JT. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases. Cancer 2017; 123: 2219–2229.
Wipperman J, Neil T, Williams T. Cervical cancer: evaluation and management. Am Fam Physician 2018; : 449–454.
American Cancer Society. Cervical Cancer Causes, Risk Factors, and Prevention. 2021.https://www.cancer.org/content/dam/CRC/PDF/Public/8600.00.pdf (accessed 2 Nov2022).
Kan Ö, Görkem Ü, Bariş A, Koçak Ö, Toğrul C, Yildirim E. Kanser erken teşhis ve tarama eğitim merkezleri’ne (KETEM) başvuran kadınlarda Human Papillomavirüs (HPV) sıklığının değerlendirilmesi ve genotiplerin analizi. Turk Hijyen ve Deneysel Biyoloji Dergisi 2019; 76: 163–168.
Turkey National Household Health Survey. Türkiye Hanehalkı Sağlık Araştırması: Bulaşıcı Olmayan Hastalıkların Risk Faktörleri Prevalansı. 2017.https://cdn.who.int/media/docs/default-source/ncds/ncd-surveillance/data-reporting/turkey/factsheet-steps-turkey-tur-08.10.2018.pdf?sfvrsn=6e6c0c0d_1&download=true. (accessed 3 Nov2022).
Rahman S, Gultekin M, Lassi ZS. Effective approaches towards eliminating cervical cancer from low-and middle-income countries amid COVID-19 pandemic Commentary. Int J Gynecol Cancer 2020; 30: 1848–1849.
World Health Organization (WHO) (2020a). Global strategy to accelerate the elimination of cervical cancer as a public health problem. https://www.who.int/publications/i/item/9789240014107 (accessed 3 Nov2022).
Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram‐Baptiste D, Saslow D et al. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 2019; 69: 184–210.
T.R. Ministry of Health GD of PHCD. Kanser Taramaları. T.R. Ministry of Health, General Directorate of Public Health, Cancer Department . 2021.https://hsgm.saglik.gov.tr/tr/kanser-taramalari (accessed 3 Nov2022).
Göl İ, Erkin Ö. What Do the Adults Know About the Cancer Screening Programs? Turkish Journal of Family Medicine and Primary Care 2019; 13: 167–176.
Basu P, Lucas E, Zhang L, Muwonge R, Murillo R, Nessa A. Leveraging vertical COVID-19 investments to improve monitoring of cancer screening programme – A case study from Bangladesh. Prev Med (Baltim) 2021. doi:10.1016/J.YPMED.2021.106624.
Puricelli Perin DM, Elfström KM, Bulliard JL, Burón A, Campbell C, Flugelman AA et al. Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey. Prev Med (Baltim) 2021; 151: 106642.
Walker MJ, Meggetto O, Gao J, Espino-Hernández G, Jembere N, Bravo CA et al. Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study. Prev Med (Baltim) 2021; 151: 106586.
Decker KM, Feely A, Bucher O, Singh H, Turner D, Lambert P. Evaluating the impact of the COVID-19 pandemic on cancer screening in a central Canadian province. Prev Med (Baltim) 2022; 155. doi:10.1016/J.YPMED.2022.106961.
Meggetto O, Jembere N, Gao J, Walker MJ, Rey M, Rabeneck L et al. The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study. BJOG 2021; 128: 1503–1510.
Moreland A, Herlihy C, Tynan MA, Sunshine G, Mccord RF, Hilton C et al. Timing of State and Territorial COVID-19 Stay-at-Home Orders and Changes in Population Movement — United States, March 1–May 31, 2020. 2020.https://arxiv.org/abs/1706.03409v1. (accessed 3 Nov2022).
Republic of Turkey Ministry of Health T.C. Sağlık Bakanlığı (2021a). COVID-19 Bilgilendirme Platformu. Yeni Koronavirüs Hastalığı, Evde Kal. 2021.https://covid19.saglik.gov.tr/TR-66184/yeni-koronavirus-hastaligi----evde-kal.html (accessed 3 Nov2022).
Epic Health Research Network. Preventive Cancer Screenings During COVID-19 Pandemic. 2020.https://epicresearch.org/articles/delays-in-preventive-cancer-screenings-during-covid-19-pandemic (accessed 3 Nov2022).
Song Z, Giuriato M, Lillehaugen T, Altman W, Horn DM, Phillips RS et al. Economic and Clinical Impact of Covid-19 on Provider Practices in Massachusetts. 2020. doi:10.1056/CAT.20.0441.
Sabatino SA, Thompson TD, White MC, Shapiro JA, de Moor J, Paul Doria-Rose V et al. Morbidity and Mortality Weekly Report Cancer Screening Test Receipt-United States, 2018. 2018.
Chargari C, Arbyn M, Leary A, Abu-Rustum NR, Basu P, Bray F et al. Increasing global accessibility to high-level treatments for cervical cancers. Gynecol Oncol 2022; 164: 231–241.
Ramirez PT, Chiva L, Gerda A, Eriksson Z, Frumovitz M, Fagotti A et al. COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers. Int J Gynecol Cancer 2020; 0: 1–3.
Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol 2020; 21: 1023–1034.
Castanon A, Rebolj M, Burger EA, de Kok IMCM, Smith MA, Hanley SJB et al. Cervical screening during the COVID-19 pandemic: optimising recovery strategies. Lancet Public Health 2021; 6: e522–e527.
Wentzensen N, Clarke MA, Perkins RB. Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities. Prev Med (Baltim) 2021; 151. doi:10.1016/J.YPMED.2021.106596.
Jeffery MM, D’Onofrio G, Paek H, Platts-Mills TF, Soares WE, Hoppe JA et al. Trends in Emergency Department Visits and Hospital Admissions in Health Care Systems in 5 States in the First Months of the COVID-19 Pandemic in the US. JAMA Intern Med 2020; 180: 1328–1333.
Wong Laura, Hawkins Jessica, Langness Simone, Murrell Karen, Iris Patricia, Sammann Amanda. Where Are All the Patients? Addressing Covid-19 Fear to Encourage Sick Patients to Seek Emergency Care. NEJM Catal Innov Care Deliv 2020.https://catalyst.nejm.org/doi/pdf/10.1056/CAT.20.0193 (accessed 3 Nov2022).
Wilson R, Quinn-Scoggins H, Moriarty Y, Hughes J, Goddard M, Cannings-John R et al. Intentions to participate in cervical and colorectal cancer screening during the COVID-19 pandemic: A mixed-methods study. Prev Med (Baltim) 2021; 153. doi:10.1016/J.YPMED.2021.106826.
T.R. Ministry of Health GD of PHCD. Serviks Kanseri Tarama Programı Ulusal Standartları. 2021.https://hsgm.saglik.gov.tr/tr/kanser-tarama-standartlari/listesi/serviks-kanseri-tarama-program%C4%B1-ulusal-standartlar%C4%B1.html (accessed 3 Nov2022).
Turkish Statistical Institute (TUIK). Adrese dayalı nüfus kayıt sistemi sonuçları, 2021. 2021.https://data.tuik.gov.tr/Bulten/Index?p=Adrese-Dayal%C4%B1-N%C3%BCfus-Kay%C4%B1t-Sistemi-Sonu%C3%A7lar%C4%B1-2021-45500&dil=1. (accessed 3 Nov2022).
Pourhoseingholi M, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol Hepatol Bed Bench 2013; 6: 14–17.
Karakoyunlu Şen S, Kılıç Öztürk Y. The Relationship Between Health Perception and Cancer Screening Awareness. Türk Aile Hek Derg 2020; 24: 175–183.
Polit D, Beck C. The content validity index: Are you sure you know what’s being reported? Critique and recommendations. Res Nurs Health 2006; 29: 489–497.
Yurdugul H. Ölçek geliştirme çalışmalarında kapsam geçerliği için kapsam geçerlik indekslerinin kullanılması. XIV. Ulusal Eğitim Bilimleri Kongresi Pamukkale Üniversitesi Eğitim Fakültesi: Denizli, Turkey, 2005.
Kwasi Ahorsu D, Lin C-Y, Imani V, Saffari M, Griffiths MD, Pakpour AH. The Fear of COVID-19 Scale: Development and Initial Validation. 2020. doi:10.1007/s11469-020-00270-8.
Bakioğlu F, Korkmaz O, Ercan H. Fear of COVID-19 and Positivity: Mediating Role of Intolerance of Uncertainty, Depression, Anxiety, and Stress. 2020. doi:10.1007/s11469-020-00331-y.
Sümbüloğlu K, Sümbüloğlu V. Biyoistatistik. 18th ed. Hatipoğlu Yayıncılık: Ankara, 2017.
Ayhan Başer D, Acar F, Bayer Ş, Çakır Altınyaprak E, Aksoy H, Fidancı İ et al. The Impact of COVID-19 Pandemic on Cancer Screening Program Applications: A Descriptive Study. J Mol Virol Immunol 2022; 3: 33–42.
Erdoğan P, Akkaya F. Ulusal serviks kanseri tarama programının mevsimsellik ve demografik eğilimleri: COVID-19 pandemisinin etkisi. Turkish Journal of Public Health 2022; 20: 152–162.
Göl İ., Erkin Ö. Knowledge and practices of nurses on cervical cancer, HPV and HPV vaccine in Cankiri state hospital, Turkey. J Pak Med Assoc 2016; 66: 1621–1626.
Fisher-Borne M, Isher-Witt J, Comstock S, Perkins RB. Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in ‘Back on track with screening’ quality improvement projects. Prev Med (Baltim) 2021; 151: 106681.
Davies JM, Spencer A, Macdonald S, Dobson L, Haydock E, Burton H et al. Cervical cancer and COVID—an assessment of the initial effect of the pandemic and subsequent projection of impact for women in England: A cohort study. BJOG 2022; 129: 1133–1139.
Ribeiro A, avia Corr F, Migowski A, Leal A, Martins S, Raiol T et al. Rethinking Cervical Cancer Screening in Brazil Post COVID-19: A Global Opportunity to Adopt Higher Impact Strategies. 2021. doi:10.1158/1940-6207.CAPR-21-0110.
Ivanuš U, Jerman T, Gašper Oblak U, Meglič L, Florjančič M, Strojan Fležar M et al. The impact of the COVID-19 pandemic on organised cervical cancer screening: The first results of the Slovenian cervical screening programme and registry. The Lancet Regional Health - Europe 2021; 5. doi:10.1016/J.LANEPE.2021.100101.
Miller MJ, Xu L, Qin J, Hahn EE, Ngo-Metzger Q, Mittman B et al. Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21–65 Years in a Large Integrated Health Care System — Southern California, January 1–September 30, 2019 and January 1–September 30, 2020. 2021.
World Health Organization (WHO). Rapid assessment of service delivery for NCDs during COVID-19 Publications. 2020.https://www.emro.who.int/noncommunicable-diseases/publications/rapid-assessment-of-service-delivery-for-ncds-during-covid-19.html (accessed 3 Nov2022).
Poljak M, Cuschieri K, Waheed DEN, Baay M, Vorsters A. Impact of the covid-19 pandemic on human papillomavirus–based testing services to support cervical cancer screening. Acta Dermatovenerol Alp Pannonica Adriat 2021; 30: 21–26.
Doubova S V., Leslie HH, Kruk ME, Pérez-Cuevas R, Arsenault C. Disruption in essential health services in Mexico during COVID-19: an interrupted time series analysis of health information system data. BMJ Glob Health 2021; 6. doi:10.1136/BMJGH-2021-006204.
Primary Care Collaborative. Primary Care & COVID-19: Round 23 Survey | Primary Care Collaborative. 2020.https://www.pcpcc.org/2020/11/23/primary-care-covid-19-round-23-survey (accessed 3 Nov2022).
Centers for Disease Control (CDC). Infection Control Guidance for Healthcare Professionals about Coronavirus (COVID-19) | CDC. 2020.https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control.html (accessed 3 Nov2022).
Chang J, Wignadasan W, Kontoghiorghe C, Kayani B, Singh S, Plastow R et al. Restarting elective orthopaedic services during the COVID-19 pandemic DO patients want tO have surgery? 2020; 1. doi:10.1302/2633-1462.16.BJO.
Ayhan Başer D, Acar F, Bayer Ş, Çakır Altınyaprak E, Aksoy H, Fidancı İ et al. The Impact of COVID-19 Pandemic on Cancer Screening Program Applications: A Descriptive Study. J Mol Virol Immunol 2022; 3: 33–42.
Scioscia M, Noventa M, Palomba S, Laganà AS. Effect of the COVID-19 pandemic on oncology
screenings: it is time to change course. BJOG 2021; 128: 2213–2214.
Galvez M, Rueda Y, Gomariz V. Estudio del impacto de Covid-19 en las personas con enfermedades crónicas: Informe de resultados. [Study of the impact of Covid-19 in people with chronic diseases: Report of results. 2020.https://catedradecronicidad.es/wp-content/uploads/2021/01/covid19_enfermedadcronica_2021.pdf (accessed 3 Nov2022).
Jidkova S, Hoeck S, Kellen E, le Cessie S, Goossens MC. Flemish population-based cancer screening programs: impact of COVID-19 related shutdown on short-term key performance indicators. BMC Cancer 2022; 22: 1–12.
Refbacks
- There are currently no refbacks.